Ceterix Orthopaedics is a developer of surgical tools for the treatment of soft tissue injuires, such as meniscus tears, hip and shoulder labrum tears and rotator cuff tears. The funds will be used to support the expansion of its business and development of tools.
The company also announced it has been issued two U.S. patents relating to methods of meniscal and soft tissue repair with the company’s proprietary technology, according to the report.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
